Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO ic-107706 (26 January 2022)


BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

Information Commissioner's Office
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO ic-107706 (26 January 2022)
URL: http://www.bailii.org/uk/cases/UKICO/2022/ic-107706.html
Cite as: [2022] UKICO ic-107706

[New search] [Printable PDF version] [Help]

Medicines and Healthcare Products Regulatory Agency

The complainant has requested information about adverse reactions to approved COVID-19 vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) is withholding the information under section 22(1) of the FOIA as it intends to publish it at some future date. The Commissioner’s decision is as follows: MHRA is entitled to withhold the requested information under section 22(1) of the FOIA and the public interest favours maintaining the exemption. MHRA’s refusal notice was inadequate and did not meet the requirements of section 17(3) of the FOIA. The Commissioner does not require MHRA to take any remedial steps.

FOI 17: Complaint upheld FOI 22: Complaint not upheld

Decision notice: ic-107706

BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKICO/2022/ic-107706.html